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KEVAN M SHOKAT MINIREVIEW 
Tyrosine kinases: modular signaling enzymes with 
tunable specificities 
Cytoplasmic tyrosine kinases are composed of modular domains; one (SHl) has 
catalytic activity, the other two (SH2 and SH3) do not. Kinase specificity is largely 
determined by the binding preferences of the SH2 domain. Attaching the SHl domain 
to a new SH2 domain, via protein-protein association or mutation, can thus 
dramatically change kinase function. 
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Protein kinases are one of the largest protein families identified, This is a result of the overlapping substrate 
identified to date; over 45 new members are identified specificities of many tyrosine kinases, which makes it 
each year. It is estimated that up to 4 % of vertebrate pro- difficult to dissect the individual signaling pathways by 
teins are protein kinases [l].The protein kinases are cate- scanning for unique target motifs [2]. 
gorized by their specificity for serineithreonine, tyrosine, 
or histidine residues. Protein tyrosine kinases account for The apparent promiscuity of individual tyrosine kinases 
roughly half of all kinases. They occur as membrane- is a result of their unique structural organization. 
bound receptors or cytoplasmic proteins and are involved Enzyme specificity is typically programmed by one 
in a wide variety of cellular functions, including cytokine binding site, which recognizes the substrate and also con- 
responses, antigen-dependent immune responses, cellular tains exquisitely oriented active-site functional groups 
transformation by RNA viruses, oncogenesis, regulation that help to lower the energy of the transition state for 
of the cell cycle, and modification of cell morphology the conversion of specific substrates to products.Tyrosine 
(Fig. 1). Although new tyrosine kinases are rapidly identi- kinases instead segregate catalysis and substrate binding 
tied by homology, only a handful of authentic in wivo sub- into separate domains. This segregation allows rapid 
strates of tyrosine kinases have been unequivocally modulation of the target specificity of tyrosine kinases in 
Fig. 1. Functions of tyrosine kinases in 
receptor signaling. (a) Domain structure 
of a Src-family tyrosine kinase. The SHl 
domain phosphorylates proteins on tyro- 
sine; the SH2 domain binds to phospho- 
tyrosine (Tyr-P)-containing sites; the SH3 
domain binds to proline-rich sequences 
in a type II helix. (b) Receptor complexes 
known to have tyrosine kinase activity 
(i.e., receptor tyrosine kinases) or known 
to associate with cytoplasmic tyrosine 
kinases. These tyrosine kinases in turn 
activate a number of signaling pathways 
directly or indirectly, including the Ras, 
phosphatidylinositol 3 kinase (Pl3K), 
phospholipase C-y (PLC-y), and mitogen- 
activated protein (MAP) kinase pathways. 
The ultimate result of the activation of 
these pathways is selective gene regula- 
tion. One important class of tyrosine 
kinases, the Jak family, directly phospho- 
rylate cytoplasmic targets, which then 
translocate to the nucleus and serve 
directly as transcription factors. lntegrin 
signaling leads to changes in cell mor- 
phology and cell-cell aggregation due to 
activation of kinases associated with the 
cell cytoskeleton. c-Abl is a tyrosine 
kinase known to associate with F-actin in 
the cytoplasm and with DNA in the 
nucleus. The activity of c-Abl is con- 
trolled by several nuclear factors includ- 
ing the Sermr kinase Cdc2. 
(a) 
(b) B-cell receptor Growth factor receptors 
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Fig. 2. Tyrosine kinases are made up of modular domains. Left: ribbon diagrams of the structures of SH3 [l I] (top), SH2 [15] (mid- 
dle) and SH1 [22] (bottom) domains (not to scale). Right: schematic representations of the domain structure of tyrosine kinases. 
Cytoplasmic tyrosine kinases contain at least one domain that mediates protein-protein association, such as the SH2 domain (color- 
coded yellow), SH3 domain (blue), pleckstrin homology domain (PH) or the focal adhesion targeting (FAT) domain of Fak. Src fam- 
ily kinases also carry a site for myristoylation,allowing their incorporation into the inner leaflet of the membrane bilayer. Abl also 
has a DNA-binding domain. The receptor tyrosine kinases, such as the ECF receptor, or the PDCF receptor, carry a domain for extra- 
cellular ligand binding. Hormone binding to this domain generally crosslinks the receptor molecules, causing the internal SHl 
domains to associate and phosphorylate each other. 
response to external signals and appears to provide a 
powerful strategy for transmitting signals within cells. As 
well as this, tyrosine kinases are localized in different 
parts of the cell, which is a powerful determinant of sub- 
strate availability and greatly affects the spectrum of in 
uivo kinase substrates.This review will focus primarily on 
the substrate specificity of cytoplasmic tyrosine kinases 
and how their specificity can be modulated in vivo (for 
other recent tyrosine kinase reviews see [3-71 ). 
Domain structure of kinases 
Most cytoplasmic tyrosine kinases are organized into Src 
homology 1 (SHl), SH2, and SH3 domains which are 
defined by sequence homology, structural studies of iso- 
lated single domains, and domain-swapping experiments 
(Fig. 2) [6].Th e d omains are named after those found in 
the first tyrosine kinase identified, the protein product of 
the V-SK gene of Rous sarcoma virus [8]. The SHl 
domain is responsible for catalyzing phosphate transfer to 
protein tyrosine residues, and is relatively promiscuous. 
The SH3 and SH2 domains have no catalytic activity, but 
are largely responsible for determining cellular localiza- 
tion and protein-protein association, and thus largely 
determine substrate specificity. In what follows, I will 
briefly review the binding specificities of the individual 
domains, before discussing how these different specifici- 
ties are integrated to determine the overall substrate 
selectivity of the tyrosine kinase. 
The SH3 domain recognizes proline-rich sequences that 
can adopt a polyproline type II (PPII) helix conforma- 
tion. The binding interaction was identified both by 
screening of peptide libraries [9] and by analysis of a 
number of X-ray [I 0] and NMR [l 11 structures of SH3 
domains with bound peptides. Interestingly, SH3 
domains can bind peptides in either the aminojcarboxy 
orientation or the carboxy+amino orientation [12,13]; 
binding affinities are in the low micromolar range. The 
interaction between SH3 domains and their ligands is 
now sufficiently well understood that the binding speci- 
ficity of a given SH3 domain for a given proline-rich 
peptide can be predicted. 
The binding of SH2 domains to their targets is tighter, 
with affinities in the low nanomolar range, and the speci- 
ficity of the SH2 domain of a tyrosine kinase appears to 
be the major determinant of its substrate specificity.The 
SH2 domain binds phosphotyrosine-containing protein 
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or peptide sequences with high specificity. NMR [14] 
and X-ray [15,16] structures of the free SH2 domain and 
of the complex with phosphotyrosine-containing ligands 
have been determined, and show that the SW2 domain is 
composed of two key binding pockets, one for the phos- 
photyrosine side chain, the other for the third residue on 
the carboxy-terminal side of the tyrosine. Peptide 
binding to the SH2 domain has been compared to a 
two-pronged plug fitting into a two-holed socket 1171. 
The target sequence preferences of many SH2 domains 
have been determined using a random peptide library 
approach [ 181. Th e majority of SH2 domains tested have 
non-overlapping sequence preferences. An important 
exception, however, is the Src kinase family whose nine 
members all have SH2 domains that recognize the 
pYEE1 motif. Substrate selectivity between Src family 
kinases may be guided instead by the SH3 domain [6]. 
Several tyrosine kinases contain tandem SH2 domains 
(see Fig. 2) and h ave been shown to bind selectively to 
proteins with appropriately spaced tandem phosphotyro- 
sine motifs [19].The presence of two SH2 domains pro- 
vides a mechanism for increasing the target selectivity of 
a kinase while using the same set of modular elements. 
The common occurrence of SH2 domains in kinases, 
phosphotyrosine phosphatases, and in proteins possessing 
no catalytic activity (so-called adapter proteins, see 
below) suggests that this module is highly versatile and 
can confer useful recognition properties on a number of 
proteins [6]. The SH2 domain may localize the tyrosine 
kinase to a particular receptor complex (e.g. the B-cell 
receptor complex) and allow the SHI domain to phos- 
phorylate a number of substrates in the complex. Thus, 
the SH2 domain does not necessarily bind to the same 
protein that the SHl domain phosphorylates. 
The carboxy-terminal domain (SHl) is the catalytic 
domain responsible for ATP binding and transfer of the 
y-phosphate to tyrosine residues. Several crystal struc- 
tures of the highly homologous Ser/Thr kinases [20,21] 
and a recent structure of the SHl domain of the insulin 
receptor tyrosine kinase [22] have provided detailed 
structural information about the catalytic domain. The 
SHl domain is composed of a 120 amino acid amino- 
terminal domain and a 350 amino acid carboxy-termi- 
nal domain with the domain interface forming the 
active site of the enzyme and the ATP binding site. 
Information from many sources has led to the conclu- 
sion that the SHl domain is extremely promiscuous in 
its substrate specificity [l]. For example, Lawrence and 
coworkers [23] showed that the SHl domain of Src will 
phosphorylate many divergent substrates; u-Tyr-con- 
taining peptides are phosphorylated almost as efficiently 
as the corresponding L-Tyr-containing peptides, serine 
residues can be phosphorylated with modest efficiency, 
and even aliphatic alcohols containing 2-10 methylene 
groups between the phosphate acceptor and the peptide 
chain are phosphorylated.The SHl domain ofAb1 can 
even accept nucleotides other than ATP as phosphate 
donors with modest efficiency (the I&S for the different 
nucleotide triphosphates tested are: ATP, 18 PM; GTP, 
1.6 mM; CTP, 5.5 mM; and UTP, 6.9 mM (241). 
/II vitro specificity of tyrosine kinases 
The in vitro specificities of a number of tyrosine 
kinases have been determined using peptide libraries 
(25,261. Sonjyang et al. [26] synthesized a library of 
l5-amino-acid peptides containing a fixed Tyr at posi- 
tion seven. The four residues preceding and following 
this residue were randomized among all amino acids 
except for Trp, Cys, Tyr, Ser and Thr for a total possible 
degeneracy of 15* = 2.56 x 10”. Aliquots (1 mg, 6.7 x 
lo-‘M) of the peptide library were phosphorylated in 
vitro by individual tyrosine kinases, and the phosphory- 
lated sequences (<lo/O) were separated and analyzed by 
amino-terminal sequence analysis. After an adjustment 
to control for different coupling efficiencies, it was pos- 
sible to assign a scale of preferences in which a value of 
15 denotes absolute specificity for one residue over the 
14 other possible amino acids and a value of 1 indicates 
no sequence preference. The most specific tyrosine 
kinase tested (c-Fps) had a maximal preference of 4.5 
for Glu next to the phosphotyrosine, on the carboxy- 
terminal side. Most of the tyrosine kinases tested 
showed preference values of 2-3 for residues flanking 
the phosphorylated tyrosine. The Ser/Thr-specific 
protein kinases were also studied by the same method 
[27], and found to have much greater target selectivity. 
The most specific Ser/Thr kinase in the study was 
cyclin B-Cdc2 which preferred proline carboxy-termi- 
nal to the phosphoserine, with a value of 11.2. Other 
Ser/Thr kinases generally gave preference values in the 
range of 5 to 9. 
Control of tyrosine kinase specificity in vivo 
This sophisticated peptide library approach as well as 
many in viva studies have demonstrated that the tyrosine 
kinases do not display nearly the same levels of intrinsic 
substrate specificity as the Ser/Thr-specific protein 
kinases. Caution must therefore be used when applying 
in vitro methods for assessing substrate specificity of tyro- 
sine kinases to in vim target specificities. Since the level 
of intrinsic specificity is small, selectivity must be deter- 
mined by other factors, such as competition for a limited 
number of targets.This would allow small differences in 
substrate specificity in vitro to give much higher selectivi- 
ties in viva. The intracellular localization of tyrosine 
kinases is also critical in determining substrate specificity. 
For example, mutations that abrogate amino-terminal 
myristoylation of Src family members, preventing them 
from localizing to the cell membrane, block their ability 
to transform cells [28,29]. In addition to tyrosine kinase 
activity, the specificity and activity of protein tyrosine 
phosphatases in cells is critical for the control of the 
steady-state level of tyrosine phosphorylation [l]. 
Another mechanism for determining substrate selectivity 
is regulation of the pleiotropic catalytic SHl domain by 
the SH3 and SH2 domains. For example, in the case of 
Src and Abl it has been shown that the SH3 domains 






Modulation of tyrosine kinase specificity by associated proteins 
What is the physiological significance of the highly trans- 
forming hybrid kinase composed of the Crk SH2 domain 
and Abl SHl domain? To answer this question Mayer et 
al. [33] looked in vitro at the phosphorylation of a sub- 
<2 
strate of c-Abl - a protein called ~130. Upon transfor- 
mation by Abl or by v-Crk, ~130 is hyperphosphorylated 
Src 
I 1200 
at a number of tyrosine residues. But wild-type Abl does 
not significantly hyperphosphorylate ~130 in vitro, sug- 
Src Abl 
510 
gesting that a cellular factor is required to bring Abl close 
to ~130. A hybrid kinase composed of the Crk SH2 
Abl domain and the Abl SHl domain does hyperphosphory- 
460 late ~130 in vitro, however, suggesting that the Crk SH2 
Crk domain was itself sufficient to localize the hybrid protein 
I 22000 to ~130 (Fig. 4). Strikingly, wild-type Abl could hyper- 
Crk Src phosphorylate ~130 in the presence of Crk in a processive 
14000 manner. These data and the finding that Crk and Abl are 
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stably associated in viva (via the central SH3 domain of 
& Crk and a proline-rich sequence in Abl) strongly suggest 
that the substrate specificity ofAb1 is modulated by non- 
covalent association with Crk [35]. This finding dramati- 
cally shows that modules from non-covalently associated 
proteins can tune the specificity of these versatile cata- 
lysts. In terms of catalyst design, if substrate specificity 
needs to be modulated in response to other signals (i.e. 
Crk or other adapters) it is critical for the SHl domain to 
have little intrinsic substrate specificity 
Fig. 3. Varying the combinations of SH2 and SH3 domains 
attached to an SHl domain can have large effects on its trans- 
forming activity in cells. Wild-type Src or Abl (top) are not trans- 
forming (transforming activity is measured as focus-forming units 
per plate in a lawn of transfected 3T3 cells [31]). When the SH3 
domain is deleted, the transfected cells are transformed 10 000 
(Abl) or 1200 (Src) times more often. Deleting the SH2 domain 
reduced transforming activity in both cases; replacing it with the 
Crk SH2 domain enhanced transforming activity. 
negatively regulate kinase activity, either by recruiting an 
inhibitor to the protein, or by binding to a carboxy-ter- 
minal region of the kinase, causing inhibition [3,30].Viral 
tyrosine kinases often lack the SH3 domain, and are 
therefore constitutively active and highly transforming. 
Deletion of the SH3 domain of c-Abl causes an increase 
in transformation efficiency of five orders of magnitude. 
The SH3 domains in these two kinases can be viewed 
primarily as on/off switches for catalytic activity [31]. 
Wang and coworkers have identified the carboxyl-termi- 
nal repeated domain (CTD) of mammalian RNA poly- 
merase II as a true in viva substrate of c-Abl [36]. 
Strikingly, the CTD is hyperphosphorylated by c-Abl in 
Deletion of the SH2 domain of Src or Abl, in contrast, 
results in mutants that are less able to transform cells, 
although their in vitro kinase activity, assayed on synthetic 
substrates, is not affected [32,33].Thus, an SH2 domain is 
necessary to guide the catalytic SHl domain to the targets 
responsible for the transformation of normal cells. To 
examine this requirement further, hybrid kinases with 
SH2 domains from one kinase and SHl domains from 
another were constructed (Fig. 3) [31]. Hybrids between 
Src and Abl have diminished transforming activities (Fig. 
3). But when Src or Abl SHl domains were coupled to 
the SH2 domain derived from the protein Crk, the trans- 
forming activities were increased.The protein Crk is a so- 
called adapter protein. It possesses one SH2 and two SH3 
domains but no SHl domain and thus has no catalytic 
activity [34].Thus it appears that the Crk SH2 domain is 
even better than the Src or Abl SH2 domains at directing 
the SHl domain of either of these kinases to the targets 
responsible for transforming activity. Clearly, the phospho- 
tyrosine-binding domain (SH2) is the determining factor 
in specifying the function of the catalytic (SHl) domain. 
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Fig. 4. Protein-protein interactions alter the specificity of Abl [33]. 
Abl does not bind directly to ~130, but Abl and Crk can associate 
due to interactions between the central Crk SH3 domain and a 
proline-rich sequence in Abl (left). When Crk recognizes phos- 
phorylated ~130, Abl is also recruited to the complex and phos- 
phorylates it at a new site. Right: in a cell transfected with a hybrid 
protein comprising the Abl SHl domain and the Crk SH2 domain, 
binding and phosphorylation occurs directly, without requiring 
protein-protein association. Green circles, phosphate groups. 
Modular function of protein tyrosine kinases Shokat 51s 
a processive manner on up to 52 tyrosine residues 1371. 
Importantly, the SH2 domain of Abl is necessary to 
mediate the processive phosphorylation of CTD. 
Although it is necessary, the SH2 domain ofAb1 is not 
sufficient to mediate phosphorylation of CTD; a hybrid 
kinase composed of the Abl SH2 domain and the Src 
SHl domain does not phosphorylate CTD in a proces- 
sive manner.These studies suggest that it is the combina- 
tion of the Abl SHl and SH2 domains that is essential for 
processive phosphorylation of physiological substrates. It 
has been proposed that, as a general rule, the specificity 
of the SH2 domain is coordinated with the modest 
specificity of the SHl domain in cytoplasmic tyrosine 
kinases [26]. Thus, the SH2 domain of Abl would be 
expected to bind the product of the phosphorylation 
catalyzed by the SHl domain on CTD, allowing proces- 
sive phosphorylation. But how is CTD initially phospho- 
rylated? Wang and coworkers have shown that another 
domain of Abl, carboxy terminal to SHl, contains a 
binding site for unphosphorylated CTD [37]. 
Conclusions 
The tyrosine kinases are one of the largest and most 
important families of proteins in vertebrates. They fimc- 
tion in a fundamentally different manner from most 
enzymes. Rather than having a single active site, the tyro- 
sine kinases have separate domains for substrate recogni- 
tion (SH3 and SH2) and chemical catalysis (SHl). The 
segregation of these two functions allows the specificity 
of kinases to be rapidly modulated, for example by associ- 
ation with other SH2/SH3-containing adapter proteins. 
The segregation of catalysis and binding into different 
domains and the poor intrinsic specificity of tyrosine 
kinases in vitro has made assignment of the precise in vivo 
targets of protein tyrosine kinases difficult to determine. 
New strategies for identifying cellular substrates of indi- 
vidual tyrosine kinases would greatly facilitate the study of 
tyrosine kinase signaling. By identifjring each kinase’s sub- 
strate under true in vivo signaling conditions, the molecu- 
lar logic of these signaling cascades could be more &lly 
understood. Furthermore, identification of the in vim 
targets of oncogenic or viral kinases will provide critical 
targets for rational drug design. Our laboratory and others 
are currently developing novel chemical approaches for 
identifying in vivo substrates of tyrosine kinases. 
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